Thursday, 30 October 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 30 October 2025
News

J&J sues to protect $74M franchise

Posted 30 October 2025 AM

Johnson & Johnson Innovative Medicine has taken steps to protect a $74 million franchise from early competition.

A lawsuit filed in the Federal Court under the former name of J&J's pharmaceutical arrm, Janssen, claims that Juno has threatened to infringe a patent protecting its schizophrenia treatments by ignoring its request for an undertaking that Juno would not supply or cause the PBS listing of any of its products in Australia before the expiry of the patent.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (13)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (3)

Other (11)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.